GC
Akesobio kicks off virtual roadshow for HK IPO
Akesobio, a Chinese biopharmaceutical firm, has launched an online-only roadshow for its up to HK$2.58bn ($332.9m) IPO amid numerous country-wide lockdowns globally to combat the Covid-19 coronavirus pandemic.
A seven-strong syndicate began taking orders for the trade on Tuesday morning in Hong Kong. To navigate the restrictions on face-to-face contact caused by the coronavirus, bookbuilding is being conducted entirely through video conference calls, said a source close to the deal.
“There were physical meetings at the ...Already a subscriber? Login
